Collection of biological samples for neurological syndromes
Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection
This study is collecting samples from people with Paraneoplastic Neurological Syndromes or Autoimmune Encephalitis to see if it can help improve how these conditions are diagnosed and treated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3500 (estimated) |
| Sex | All |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 62 sites (Pointe à Pitre, Guadeloupe and 61 other locations) |
| Trial ID | NCT05198661 on ClinicalTrials.gov |
What this trial studies
This study focuses on collecting biological samples from patients diagnosed with Paraneoplastic Neurological Syndromes (PNS) or Autoimmune Encephalitis (AE) to improve diagnosis and treatment options. By gathering sera, cerebrospinal fluid, and other biological materials, the study aims to enhance understanding of these rare neuroimmune disorders. The goal is to facilitate faster and more accurate diagnoses, ultimately leading to better patient outcomes.
Who should consider this trial
Good fit: Ideal candidates include patients with well-characterized antibodies in their serum or cerebrospinal fluid and a neurological disorder compatible with PNS or AE.
Not a fit: Patients who refuse consent or are under guardianship will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic methods and treatment strategies for patients with rare neuroimmune syndromes.
How similar studies have performed: While this approach is focused on biological sample collection, similar studies have shown promise in improving diagnosis and treatment for neuroimmune disorders.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient with consent * Patient with well-characterized antibodies in serum or cerebrospinal fluid or not * Patient with neurological disorder compatible with PNS or auto-immune encephalitis Exclusion Criteria: * Refusal of consent * Patient under guardianship
Where this trial is running
Pointe à Pitre, Guadeloupe and 61 other locations
- Neurology — Pointe à Pitre, Guadeloupe, France (Not_yet_recruiting)
- Neurology — Aix-en-Provence, France (Not_yet_recruiting)
- Neurologie — Amiens, France (Not_yet_recruiting)
- Neurology — Angers, France (Not_yet_recruiting)
- General neurology — Annecy, France (Not_yet_recruiting)
- Neurology — Avignon, France (Not_yet_recruiting)
- Neurologie — Bayonne, France (Not_yet_recruiting)
- Neurology — Besançon, France (Recruiting)
- Neurology — Bobigny, France (Not_yet_recruiting)
- Neurology — Bordeaux, France (Not_yet_recruiting)
- Neurology — Brest, France (Not_yet_recruiting)
- Intensive care medicine — Cannes, France (Not_yet_recruiting)
- Neurologie — Chambéry, France (Not_yet_recruiting)
- Neurology — Clermont-Ferrand, France (Not_yet_recruiting)
- Neurologie — Colmar, France (Not_yet_recruiting)
- Neurology — Créteil, France (Not_yet_recruiting)
- General, Vascular and Degenerative Neurology — Dijon, France (Not_yet_recruiting)
- Neurology — Épinal, France (Recruiting)
- Internal and general practitioner — Gap, France (Not_yet_recruiting)
- Neurologie — Grenoble, France (Recruiting)
- Neurology — La Roche-sur-Yon, France (Not_yet_recruiting)
- Neurology — Lille, France (Not_yet_recruiting)
- Neurology — Lille, France (Recruiting)
- Neurology — Limoges, France (Not_yet_recruiting)
- Neurology — Lisieux, France (Not_yet_recruiting)
- Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites autoimmunes — Lyon, France (Recruiting)
- Adult Neurology and Neuropsychology — Marseille, France (Not_yet_recruiting)
- Neurologie — Marseille, France (Not_yet_recruiting)
- Neurology — Marseille, France (Not_yet_recruiting)
- Neurology — Mâcon, France (Not_yet_recruiting)
- Neurology — Metz, France (Not_yet_recruiting)
- Neurology — Montivilliers, France (Not_yet_recruiting)
- General Neurology — Montpellier, France (Not_yet_recruiting)
- General medicine — Mulhouse, France (Not_yet_recruiting)
- Neurologie — Nancy, France (Not_yet_recruiting)
- Neurology — Nantes, France (Not_yet_recruiting)
- Neurologie — Nice, France (Not_yet_recruiting)
- Neurology — Nîmes, France (Not_yet_recruiting)
- Neurology — Paris, France (Not_yet_recruiting)
- Neuropediatrics — Paris, France (Not_yet_recruiting)
- Intensive Care Medicine — Paris, France (Not_yet_recruiting)
- Neurology — Paris, France (Not_yet_recruiting)
- Onco-neurology — Paris, France (Not_yet_recruiting)
- Neurology adult — Paris, France (Not_yet_recruiting)
- Neurology, neuropsychology and language rehabilitation — Poitiers, France (Not_yet_recruiting)
- Neurology — Reims, France (Not_yet_recruiting)
- Neurology — Rennes, France (Not_yet_recruiting)
- Vascular and general neurology — Rouen, France (Not_yet_recruiting)
- Neurology — Saint-Brieuc, France (Not_yet_recruiting)
- Neurology — Saint-Denis, France (Not_yet_recruiting)
+12 more sites — see ClinicalTrials.gov for the full list.
Study contacts
- Study coordinator: Jerome HONNORAT, Pr
- Email: jerome.honnorat@chu-lyon.fr
- Phone: 4 72 35 78 06
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.